Sarepta Therapeutics

VYONDYS-53

Manufacturer:

Sarepta Therapeutics

Vyondys-53 HCPCS:

J1429

HCPCS Code Descriptor:

Injection, golodirsen, 10 mg

Category:

J Code

Vyondys-53 NDCs:

60923-0465-02

Primary Type:

Genetic Disorder

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Vyondys-53 CPT Codes:

Potential CPT administration codes for Vyondys-53 can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Vyondys-53:

VYONDYS-53 is a Genetic Disorder drug manufactured by Sarepta Therapeutics and administered via the Intravenous route of administration. The J Code: J1429 is aligned to the drug VYONDYS-53.

ACCESS PRICING AND MORE BY REGISTERING

J1429 Added Date:

July 1, 2020

J1429 Effective Date:

July 1, 2020

J1429 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Vyondys-53 billing and coding information.
Vyondys-53 patient assistance information can be found through NS Pharma at the URL: https://www.viltepso.com/support
VYONDYS-53 prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for VYONDYS-53. Please check back in a few weeks.